Transforming growth factor-β modulates plasminogen activator activity and plasminogen activator inhibitor type-1 expression in human keratinocytes in vitro

24Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Transforming growth factor beta (TGF-β) is a multifunctional mediator with effects on cellular growth, differentiation, and extracellular matrix (ECM) metabolism. Because TGF-β stimulates fibronectin expression in cultured human keratinocytes, we wished to determine whether it might also affect ECM degradation through the plasminogen activator (PA)-plasminogen activator inhibitor (PAI) system. Immunofluorescence of human keratinocytes using a monospecific antiserum to type I PAI (PAI-1) showed enhanced cellular and ECM staining when they were cultured in the presence of TGF-β. The antiserum also identified an Mr 50,000 protein in conditioned media that was markedly enhanced by TGF-β. A corresponding stimulation of PAI-1 mRNA was demonstrated by quantitative RNA blot analysis. Total plasminogen activating activity of conditioned medium was markedly decreased by TGF-β. Zymography showed this to be at least partially due to decreased secreted urokinase activity. TGF-β may play an important role in stabilizing the provisional matrix synthesized by keratinocytes in healing wounds. © 1990.

Cite

CITATION STYLE

APA

Wikner, N. E., Elder, J. T., Persichitte, K. A., Mink, P., & Clark, R. A. F. (1990). Transforming growth factor-β modulates plasminogen activator activity and plasminogen activator inhibitor type-1 expression in human keratinocytes in vitro. Journal of Investigative Dermatology, 95(5), 607–613. https://doi.org/10.1111/1523-1747.ep12505603

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free